When patients and physicians disagree on the use of genetic engineering technology, physicians must act in accordance with professional ethics and society's guidelines.
Genetic information is redefining what society and the medical profession considers to be normal and what departures from the norm are deserving of medical intervention.
Medical ethicists have discussed the use of race classification in determining disease prevalence and the response of specific ethnic groups to different medications.
Adrienne W. Henize, JD and Andrew F. Beck, MD, MPH
Data on certain chronic conditions’ prevalence, incidence of potentially preventable morbidity, and health-harming legal factors influence approaches to care.
AMA J Ethics. 2024; 26(8):E648-654. doi:
10.1001/amajethics.2024.648.
Professor Adrienne W. Henize joins Ethics Talk to discuss her article, coauthored with Dr Andrew F. Beck: “What Are Epidemiological Foundations for Integrating Legal Services Into Health Care Settings?”
Dr Aysha Akhtar joins Ethics Talk to discuss her article, coauthored with Mikalah Singer, “With What Should We Replace Nonhuman Animals in Biomedical Research Protocols?”
Erin Sharoni joins Ethics Talk to discuss her article: “Which Concepts Are Key to Transitioning From Nonhuman Animal Models to Engineered Microphysiological Systems in Biomedical Research?”
Dr David DeGrazia joins Ethics Talk to discuss why the “3 R’s” of nonhuman animal research might not be sufficient to promote good science, ethics, and nonhuman animal welfare.
Laurie Sellars joins Ethics Talk to discuss her article, coauthored with Dr Jeff Sebo: “How Should Treatment of Animals Beyond the Lab Factor Into Institutional Review?”
